AZA-MS: a novel multiparameter mass spectrometry method to determine the intracellular dynamics of azacitidine therapy in vivo
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
AZA-MS: a novel multiparameter mass spectrometry method to determine the intracellular dynamics of azacitidine therapy in vivo
Authors
Keywords
-
Journal
LEUKEMIA
Volume 32, Issue 4, Pages 900-910
Publisher
Springer Nature
Online
2017-12-18
DOI
10.1038/leu.2017.340
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Integrative Genomics Identifies the Molecular Basis of Resistance to Azacitidine Therapy in Myelodysplastic Syndromes
- (2017) Ashwin Unnikrishnan et al. Cell Reports
- Simultaneous quantitative determination of 5-aza-2′-deoxycytidine genomic incorporation and DNA demethylation by liquid chromatography tandem mass spectrometry as exposure-response measures of nucleoside analog DNA methyltransferase inhibitors
- (2016) Nicole M. Anders et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- A robust and rapid liquid chromatography tandem mass spectrometric method for the quantitative analysis of 5-azacytidine
- (2015) Nicole M. Anders et al. BIOMEDICAL CHROMATOGRAPHY
- DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts
- (2015) David Roulois et al. CELL
- Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses
- (2015) Katherine B. Chiappinelli et al. CELL
- Specific molecular signatures predict decitabine response in chronic myelomonocytic leukemia
- (2015) Kristen Meldi et al. JOURNAL OF CLINICAL INVESTIGATION
- High cytidine deaminase expression in the liver provides sanctuary for cancer cells from decitabine treatment effects
- (2015) Quteba Ebrahem et al. Oncotarget
- TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients
- (2014) R. Bejar et al. BLOOD
- Quantitative determination of decitabine incorporation into DNA and its effect on mutation rates in human cancer cells
- (2014) Simin Öz et al. NUCLEIC ACIDS RESEARCH
- Genomic impact of transient low-dose decitabine treatment on primary AML cells
- (2013) J. M. Klco et al. BLOOD
- Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia
- (2013) E. Such et al. BLOOD
- Mechanisms of resistance to azacitidine in human leukemia cell lines
- (2013) Piyanuch Sripayap et al. EXPERIMENTAL HEMATOLOGY
- Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia
- (2013) Raphaël Itzykson et al. JOURNAL OF CLINICAL ONCOLOGY
- Quantitative determination of azacitidine triphosphate in peripheral blood mononuclear cells using liquid chromatography coupled with high-resolution mass spectrometry
- (2013) Ellen J.B. Derissen et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Predictive factors of response and survival among chronic myelomonocytic leukemia patients treated with azacitidine
- (2013) Lionel Adès et al. LEUKEMIA RESEARCH
- Identification of direct targets and modified bases of RNA cytosine methyltransferases
- (2013) Vahid Khoddami et al. NATURE BIOTECHNOLOGY
- Hematopoietic stem cell and progenitor cell mechanisms in myelodysplastic syndromes
- (2013) W. W. Pang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Reassembly of Nucleosomes at the MLH1 Promoter Initiates Resilencing Following Decitabine Exposure
- (2013) Luke B. Hesson et al. PLoS Genetics
- In Vivo Quantification of Active Decitabine-Triphosphate Metabolite: A Novel Pharmacoanalytical Endpoint for Optimization of Hypomethylating Therapy in Acute Myeloid Leukemia
- (2012) Hongyan Wang et al. AAPS Journal
- RNA-dependent inhibition of ribonucleotide reductase is a major pathway for 5-azacytidine activity in acute myeloid leukemia
- (2012) J. Aimiuwu et al. BLOOD
- Revised International Prognostic Scoring System for Myelodysplastic Syndromes
- (2012) P. L. Greenberg et al. BLOOD
- Decitabine triphosphate levels in peripheral blood mononuclear cells from patients receiving prolonged low-dose decitabine administration: a pilot study
- (2012) Robert S. Jansen et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Effects of tetrahydrouridine on pharmacokinetics and pharmacodynamics of oral decitabine
- (2011) D. Lavelle et al. BLOOD
- Outcome of High-Risk Myelodysplastic Syndrome After Azacitidine Treatment Failure
- (2011) Thomas Prébet et al. JOURNAL OF CLINICAL ONCOLOGY
- Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias
- (2011) R Itzykson et al. LEUKEMIA
- Mechanisms of Resistance to Decitabine in the Myelodysplastic Syndrome
- (2011) Taichun Qin et al. PLoS One
- Activity of azacitidine in chronic myelomonocytic leukemia
- (2010) Rubens Costa et al. CANCER
- A Comparison of Azacitidine and Decitabine Activities in Acute Myeloid Leukemia Cell Lines
- (2010) Paul W. Hollenbach et al. PLoS One
- Early epigenetic changes and DNA damage do not predict clinical response in an overlapping schedule of 5-azacytidine and entinostat in patients with myeloid malignancies
- (2009) T. E. Fandy et al. BLOOD
- MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation
- (2009) M. E. Figueroa et al. BLOOD
- Azacytidine Inhibits RNA Methylation at DNMT2 Target Sites in Human Cancer Cell Lines
- (2009) M. Schaefer et al. CANCER RESEARCH
- Chemical Decomposition of 5-Aza-2′-deoxycytidine (Decitabine): Kinetic Analyses and Identification of Products by NMR, HPLC, and Mass Spectrometry
- (2009) Daniel K. Rogstad et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Targeting DNA Methylation
- (2009) J.-P. J. Issa et al. CLINICAL CANCER RESEARCH
- Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
- (2009) Pierre Fenaux et al. LANCET ONCOLOGY
- Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine
- (2008) Carlo Stresemann et al. INTERNATIONAL JOURNAL OF CANCER
- DNA methylation determination by liquid chromatography-tandem mass spectrometry using novel biosynthetic [U-15N]deoxycytidine and [U-15N]methyldeoxycytidine internal standards
- (2008) E. P. Quinlivan et al. NUCLEIC ACIDS RESEARCH
- DNA digestion to deoxyribonucleoside: A simplified one-step procedure
- (2007) Eoin P. Quinlivan et al. ANALYTICAL BIOCHEMISTRY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now